CSIMarket Company Name, Ticker, Industry, else..
 
Kyntra Bio Inc   (NASDAQ: KYNB)
 
Price: $7.8100 $0.03 0.386%
Day's High: $7.894999980926514 Week Perf: -3.64 %
Day's Low: $ 7.80 30 Day Perf: 15.53 %
Volume (M): 4,114 52 Wk High: $ 12.60
Volume (M$): $ 0 52 Wk Avg: $8.36
Open: $7.83 52 Wk Low: $6.32



 Market Capitalization (Millions $) 32
 Shares Outstanding (Millions) 4
 Employees -
 Revenues (TTM) (Millions $) 7
 Net Income (TTM) (Millions $) 164
 Cash Flow (TTM) (Millions $) -6
 Capital Exp. (TTM) (Millions $) 0

Business Description


The company is involved in the development and commercialization of product candidates, conducting ongoing and planned preclinical and clinical trials. It focuses on securing regulatory approvals, managing intellectual property, and establishing commercial operations to support product market entry.


   Company Address: 350 Bay Street San Francisco 94133 CA
   Company Phone Number: 978-1200   Stock Exchange / Ticker: NASDAQ KYNB


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
BMY   -0.83%    
JNJ   -1.58%    
LLY   -5.21%    
MRK   -3.75%    
PFE   -0.07%    
TEVA   -5.7%    
• View Complete Report
   





Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) 0.19
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 4.25
Price to Sales (Expected) -
Price to Book -
PEG (TTM) -

Financial Strength Current
Quick Ratio 3.1
Working Capital Ratio 3.61
Leverage Ratio (MRQ) -
Total Debt to Equity -
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) 40.45 $
Revenues (TTM) 1.84 $
Cash Flow (TTM) -
Cash 21.56 $
Book Value -
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) -
Net Income per Employee (TTM) -
Receivable Turnover Ratio (TTM) 5.4
Inventory Turnover Ratio (TTM) 1.22
Asset Turnover Ratio (TTM) 0.05

Profitability Ratios Current
Gross Margin (MRQ) -9.84 %
Operating Margin (MRQ) -369.66 %
Net Margin (MRQ) -406.58 %
Net Cash Flow Margin (MRQ) -290.93 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) 120.14 %
Return On Investment (TTM) 221.8 %
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -



Kyntra Bio Inc's Segments
Drug Product Revenue Net    93.42 % of total Revenue
Drug Product Revenue Net Astellas Agreement    93.63 % of total Revenue
Drug Product Revenue Net Astellas Agreement Japan    -58.61 % of total Revenue
Drug Product Revenue Net Astellas Agreement Europe    152.03 % of total Revenue
Europe Astellas Europe Agreement    88.28 % of total Revenue
Drug Product Revenue Net Europe Astellas Agreement    152.03 % of total Revenue
Drug Product Revenue Net Japan Astellas Agreement    -58.61 % of total Revenue
Drug Product Revenue Net API Shipment    58.86 % of total Revenue
Bulk Drug Product Astellas Europe Agreement    165.86 % of total Revenue
Bulk Drug Product Europe Astellas Europe Agreement    13.38 % of total Revenue
Bulk Drug Product Europe Astellas Europe Agreement Royalty Revenue    40.13 % of total Revenue





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.